These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18328362)

  • 1. Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men.
    Chang Y; Ryu S; Sung E; Woo HY; Oh E; Cha K; Jung E; Kim WS
    Metabolism; 2008 Apr; 57(4):569-76. PubMed ID: 18328362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.
    Ryu S; Chang Y; Woo HY; Lee KB; Kim SG; Kim DI; Kim WS; Suh BS; Jeong C; Yoon K
    Am J Kidney Dis; 2009 Jan; 53(1):59-69. PubMed ID: 18838200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and metabolic syndrome-related chronic kidney disease in nondiabetic, nonhypertensive adults.
    Yoon YS; Park HS; Yun KE; Kim SB
    Metabolism; 2009 Dec; 58(12):1737-42. PubMed ID: 19615700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study.
    Ninomiya T; Kiyohara Y; Kubo M; Tanizaki Y; Tanaka K; Okubo K; Nakamura H; Hata J; Oishi Y; Kato I; Hirakata H; Iida M
    Am J Kidney Dis; 2004 Sep; 44(3):437-45. PubMed ID: 15332216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults.
    Kurella M; Lo JC; Chertow GM
    J Am Soc Nephrol; 2005 Jul; 16(7):2134-40. PubMed ID: 15901764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal increase in gamma-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men.
    Ryu S; Chang Y; Woo HY; Yoo SH; Choi NK; Lee WY; Kim I; Song J
    Metabolism; 2010 May; 59(5):683-9. PubMed ID: 19922966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study.
    Lucove J; Vupputuri S; Heiss G; North K; Russell M
    Am J Kidney Dis; 2008 Jan; 51(1):21-8. PubMed ID: 18155529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men.
    Ryu S; Chang Y; Kim DI; Kim WS; Suh BS
    Clin Chem; 2007 Jan; 53(1):71-7. PubMed ID: 17110470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blockers for coronary heart disease in chronic kidney disease.
    Chonchol M; Benderly M; Goldbourt U
    Nephrol Dial Transplant; 2008 Jul; 23(7):2274-9. PubMed ID: 18187497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and the development of chronic kidney disease among 118 924 non-diabetic Taiwanese in a retrospective cohort.
    Sun F; Tao Q; Zhan S
    Nephrology (Carlton); 2010 Feb; 15(1):84-92. PubMed ID: 20377775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
    Zoppini G; Targher G; Chonchol M; Perrone F; Lippi G; Muggeo M
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):580-6. PubMed ID: 19196499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The association of cardiovascular risk factors with nonalcoholic fatty liver disease in health checkup examinees].
    Yu JH; Lee KS; Lee SY; Hong AR; Park YS
    J Prev Med Public Health; 2008 Nov; 41(6):407-12. PubMed ID: 19037170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults.
    Lee JE; Choi SY; Huh W; Kim YG; Kim DJ; Oh HY
    Am J Hypertens; 2007 Nov; 20(11):1189-94. PubMed ID: 17954366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of kidney function with mortality in patients with chronic kidney disease not yet on dialysis: a historical prospective cohort study.
    Kovesdy CP; Trivedi BK; Anderson JE
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):183-8. PubMed ID: 16580621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
    Abboud I; Porcher R; Robin M; de Latour RP; Glotz D; Socié G; Peraldi MN
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk.
    Tahan V; Canbakan B; Balci H; Dane F; Akin H; Can G; Hatemi I; Olgac V; Sonsuz A; Ozbay G; Yurdakul I; Senturk H
    Hepatogastroenterology; 2008; 55(85):1433-8. PubMed ID: 18795706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronological development of elevated aminotransferases in a nonalcoholic population.
    Suzuki A; Angulo P; Lymp J; St Sauver J; Muto A; Okada T; Lindor K
    Hepatology; 2005 Jan; 41(1):64-71. PubMed ID: 15690483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.